Publication | Closed Access

“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group

Hematological MalignancyMedicineHematologyMyeloid NeoplasiaOncologyRadiation OncologyRelapsed/refractory Multiple MyelomaStandard Clinical PracticeHealth Sciences